PERSONALISED MEDICINE FOR BETTER HEALTH
About
Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. We also pioneer in R&D projects centered on integrating biomarker targets in all phases of drug development, from preclinical to post-marketing. Plexision’s technology can be adapted to
- Assess disease risk for several immunological disorders.
- Predict the success of a drug for a specific patient.
- Develop dosing recommendations for new immunological drugs.
Our state-of-the-art laboratory is CLIA-certified and located in Pittsburgh, PA.
Contact
- +1 (855) 753-9474
- info@plexision.com
- 4424 Penn Ave., #202, Pittsburgh, PA 15224 USA
Media And News
Blogs
Rapid six-hour test panel to predict CMV infection and transplant rejection
Urban construction projects are complex, and they require careful planning and monitoring to ensure that they are successful. In urban areas, construction projects
New blood test to predict antibody-mediated rejection to be presented at World Transplant Congress
Urban construction projects are complex, and they require careful planning and monitoring to ensure that they are successful. In urban areas, construction projects
T-cell and antibody immunity after COVID-19 vaccination in healthy and immunocompromised
Urban construction projects are complex, and they require careful planning and monitoring to ensure that they are successful. In urban areas, construction projects